Best Postpartum GLP-1 Providers in 2026: Ranked and Reviewed
No GLP-1 is approved for postpartum weight loss, and the labels set limits before any seller does. While breastfeeding, the answer depends on the product: the semaglutide tablets say not to, the injections leave it to you and your clinician, and the tirzepatide labels carry a small milk study. Semaglutide should come off two months or more before you try to conceive, its labels say. Tirzepatide can make the pill less reliable. The sellers below prescribe a GLP-1 and run a women's health program, menopause or PCOS care, shown on their own site when we read it on October 30, 2026. We did not check any of them for a postpartum program.
Lowest verified price: $99/mo34 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
34 postpartum GLP-1 providers compared · independently scored against our six-factor methodology.
What the labels say after pregnancy
Read on DailyMed on October 30, 2026. Take the exact product name to your clinician, because the answer differs between a pen and a pill of the same drug.
Not recommended
breastfeeding on semaglutide tablets
The Wegovy tablets label advises against breastfeeding, because SNAC, the absorption enhancer in the tablet, passes into human milk and may build up in an infant. Rybelsus and Ozempic tablets carry the same advice.[12]
Breastfeeding, drug by drug →No data
semaglutide injection in human milk
Neither injection label has human milk data for semaglutide, or data on a nursing baby. Both leave it to the mother and her clinician to set what breastfeeding gives the baby against how much she needs the drug.[13]
What the injection labels say →164 of 171
milk samples with no tirzepatide found
Eleven breastfeeding women each took one 5 mg dose; only 7 of their 171 milk samples held any measurable tirzepatide. Neither Lilly label has data on what it does to a nursing baby or to milk supply.[14]
The tirzepatide milk study →2 months
off semaglutide before a planned pregnancy
Every semaglutide label, pen or tablet, asks women to come off the drug two months or more ahead of trying to conceive, because it lingers in the body. Neither tirzepatide label sets a gap, so the timing is your clinician's to set.[12]
Stopping before a pregnancy →4 weeks
backup birth control on tirzepatide
Zepbound and Mounjaro slow the stomach and can weaken the pill. Lilly's labels say to change to a method that is not swallowed, or to use condoms or another barrier as backup for a four-week stretch at the start and again after every dose step.[14]
GLP-1s and the pill →Stop
when a pregnancy is recognized
The labels say losing weight does a pregnant patient no good and could hurt the baby. Zepbound comes off once a pregnancy is known, and so does Wegovy taken for weight.[14]
What the labels say on pregnancy →
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$109Coverage46 states + DCMedicationsSemaglutideTirzepatide - Nationwide Coverage
women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$169Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$169prepaidFlat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
Show 5 moreShow fewer
women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$179Flat at every doseCoverage50 states + DCMedicationsSemaglutideTirzepatidewomen's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$185Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide- Best Budget
women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$117.80prepaidCoverage49 statesMedicationsSemaglutideTirzepatide women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$129.14prepaidScales with doseCoverage47 statesMedicationsTirzepatideSemaglutidewomen's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
From /mo$199Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $109 | SemaglutideTirzepatide | 46 states + DC | Visit → | |
Nationwide Coverage women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $169 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $169prepaid Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $179 Flat pricing | SemaglutideTirzepatide | 50 states + DC | Visit → | |
 women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $185 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
Best Budget women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $117.80prepaid | SemaglutideTirzepatide | 49 states | Visit → | |
 women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $129.14prepaid Scales by dose | TirzepatideSemaglutide | 47 states | Visit → | |
 women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026) | $199 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → |
All 34 providers on this board, in the order this board shows them
The comparison above shows the first 8. This is the full list the filter counts refer to, in the order this board shows them; each name opens that provider’s review.
- OurView Health
- Open Water Rx
- Get Thin MD
- Luvo Health
- Rese Wellness
- Nuform Health
- Balanced Hormone Health
- Kina
- Alloy
- Kin Meds
- Zeuss
- Hers
- Joi + Blokes
- BiltRx
- PCOS Sisters
- Allara Health
- AVARA Rx
- California Trim Clinic
- Hone Health
- Henry Meds
- Gaya Wellness
- LaSara Medical Group
- UR Meds
- Evernow
- Maven Clinic
- Medivive
- Midi Health
- Nurx
- Evolve Telemed
- Steady State Health
- RegenCen
- BodyLogicMD
- Defy Medical
- Bodyshop Wellness
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Detailed Reviews
OurView Health
Best for: women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
OurView Health sells compounded semaglutide at $109 a month and compounded tirzepatide at $129, one price whatever the dose, with no membership fee and free shipping. Paying 3 months up front lowers that to $99 and $119. Prescribers come from Telegra's network, and Boudreaux's New Drug Store in Louisiana compounds and ships the medication. It serves 46 states plus DC and also sells hormone care and peptides.
Score Breakdown
Pros
- ✓Semaglutide costs $109 a month, 45% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $129 a month, 52% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves 46 states and DC
- ✓Names Boudreaux's New Drug Store as the pharmacy that fills its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to OurView Health
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Open Water Rx
Best for: women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
Open Water Rx is a Tampa, Florida telehealth platform (Open Water Rx LLC, which also trades as Surfbound and Surfbound Health) for GLP-1 weight loss, longevity and men's health. Compounded semaglutide is $169 and tirzepatide $219 for a one-month plan, all-inclusive and the same at every dose, with three- and six-month plans and oral tablets also priced on its own site. Its pharmacy partners are Emerald (Tampa, FL), Striker (Katy, TX), Foothills (Tempe, AZ) and EPIQ Scripts (Texas), each listed with a state license.
Score Breakdown
Pros
- ✓Semaglutide costs $169 a month, 15% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $219 a month, 19% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓Names 3 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Open Water Rx
- ✓Offers both oral and injectable options, so the format is your choice
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Get Thin MD
Best for: women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
Score breakdown, pros and cons
Compounded semaglutide at Get Thin MD costs $199 a month, or $169 a month on a 3-month plan paid up front. Compounded tirzepatide is $299 a month, and brand Zepbound or Ozempic can be prescribed where appropriate. Four partner pharmacies are named. Hair loss, HRT, NAD+, and sermorelin fill out a broader wellness menu. The model is async and nationwide, with neither an office visit nor insurance required. Its flat-price pledge reads: "same price, every dose, no hidden fees."
Score Breakdown
Pros
- ✓Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits, shipping and coaching
- ✓Serves all 50 states
- ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Get Thin MD
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Luvo Health
Verified partnerBest for: women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
Score breakdown, pros and cons
Compounded and brand GLP-1s from Luvo Health, Inc., sold beside a microdosing program and longevity peptides; skincare, HRT and testosterone are listed as coming soon. Billing is in 4-week blocks. Compounded semaglutide injections cost $209 per 4 weeks after a half-price first cycle, and microdose plans cost $179.
Score Breakdown
Pros
- ✓Semaglutide costs $209 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $249 a month, 7% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states and DC
- ✓We found no FDA warning letters issued to Luvo Health
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Rese Wellness
Best for: women's health care beside a GLP-1 (a menopause program on its own site, read October 30, 2026)
Score breakdown, pros and cons
Rese Wellness is a family-run telehealth company from Gilbert, Arizona, started by a nurse and her physician father, selling compounded semaglutide and tirzepatide alongside peptide, men's health and hair care. Every patient begins with a three-month program paid in one charge and shipped at once: $555 for semaglutide ($185 a month) or $897 for tirzepatide ($299 a month), with the price fixed at every dose. Later months can be bought one at a time, with no subscription.
Score Breakdown
Pros
- ✓Semaglutide costs $185 a month, 7% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication and clinician visits
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to Rese Wellness
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Related research
These pages set out the label text in full, so the conversation with your clinician starts from the same words.
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 12.Wegovy (semaglutide) prescribing information, DailyMed SPL— Novo Nordisk, via the National Library of Medicine (DailyMed).
- 13.Ozempic (semaglutide) injection prescribing information, DailyMed SPL— Novo Nordisk, via the National Library of Medicine (DailyMed).
- 14.Zepbound (tirzepatide) prescribing information, DailyMed SPL— Eli Lilly and Company, via the National Library of Medicine (DailyMed).